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ABSTRACT
Objective: To examine weight change by diabetes
status among participants receiving a Mediterranean-
style diet, physical activity, and weight loss intervention
adapted for delivery in the southeastern USA, where
rates of cardiovascular disease (CVD) are
disproportionately high.
Research design and methods: The intervention
included: Phase I (months 1–6), an individually tailored
intervention promoting a Mediterranean-style dietary
pattern and increased walking; Phase II (months 7–
12), option of a 16-week weight loss intervention for
those with BMI≥25 kg/m2 offered as 16 weekly group
sessions or 5 group sessions and 10 phone calls, or a
lifestyle maintenance intervention; and Phase III
(months 13–24), weight loss maintenance intervention
for those losing ≥8 pounds with all others receiving a
lifestyle maintenance intervention. Weight change was
assessed at 6, 12, and 24-month follow-up.
Results: Baseline characteristics (n=339): mean age
56, 77% female, 65% African-American, 124 (37%)
with diabetes; mean weight 103 kg for those with
diabetes and 95 kg for those without. Among
participants with diabetes, average weight change was
−1.2 kg (95% CI −2.1 to −0.4) at 6 months (n=92),
−1.5 kg (95% CI −2.9 to −0.2) at 12 months (n=96),
and −3.7 kg (95% CI −5.2 to −2.1) at 24 months
(n=93). Among those without diabetes, weight change
was −0.4 kg (95% CI −1.4 to 0.6) at 24 months
(n=154).
Conclusions: Participants with diabetes experienced
sustained weight loss at 24-month follow-up. High-risk
US populations with diabetes may experience clinically
important weight loss from this type of lifestyle
intervention.
Trial registration number: NCT01433484.
INTRODUCTION
Weight loss, defined by the American
Diabetes Association as a sustained reduction
of 5% of initial body weight,1 is recom-
mended for overweight and obese patients
with type 2 diabetes, while others have noted
that weight loss as small as 2 kg appears to
provide clinical benefit.2 However, weight
loss is difficult to achieve and harder to
sustain; and in general, individuals with dia-
betes have a harder time losing weight and
maintaining weight loss, when compared
Significance of this study
What is already known about this subject?
Though not well studied in the USA, particularly
among low-income and minority populations, a
Mediterranean-style dietary pattern can reduce the
risk for cardiovascular disease (CVD) among those
with and without type 2 diabetes and has been
shown in some studies to be associated with main-
tenance of weight loss.
What are the new findings?
We developed and evaluated a lifestyle and weight
loss intervention for low-income and minority resi-
dents of eastern North Carolina, with a major focus
on implementing a culturally adapted
Mediterranean-style dietary pattern while also pro-
moting physical activity. Among study participants
with diabetes, the intervention was well received
and associated with sustained weight loss at
24-month follow-up.
How might these results change the focus of
research or clinical practice?
This study demonstrates high acceptability of a
Mediterranean-style dietary pattern among low-
income and minority populations residing in eastern
North Carolina and appears to be promising as a
weight loss intervention for participants with dia-
betes. This dietary pattern and type of intervention
should be evaluated in randomized controlled trials
to further assess the intervention’s effectiveness at
improving CVD risk factors, yielding sustained
weight loss, and reducing CVD events.
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with those without diabetes.3 This is especially true for
high risk groups such as African-American women with
type 2 diabetes.4 For example, in the Action for Health
in Diabetes (Look AHEAD) trial,5 among female partici-
pants with diabetes, the year-1 weight loss was 6.8% for
African-Americans compared with 9.1% for
non-Hispanic whites. Thus, improved approaches for
promoting weight loss are needed for patients with dia-
betes and especially for groups at higher risk for obesity
and diabetes such as African-American women.
Some have argued that a variety of weight loss dietary
patterns are acceptable if they lead to weight loss.6
However, as patients with type 2 diabetes are at very high
risk for cardiovascular disease (CVD), consideration
should be given to advocating a weight loss dietary
pattern that also reduces CVD risk. When a
Mediterranean diet pattern, supplemented with olive oil
or nuts, was evaluated in the Prevención con Dieta
Mediterránea (PREDIMED) randomized trial,7 there
was a 30% reduction in CVD risk among participants
with and without diabetes. This contrasts with the lower
fat weight loss diet evaluated in Look AHEAD,8 which
led to significant weight loss but did not reduce CVD
risk.
Attention to dietary pattern as a critical component of
weight loss diets may be even more important for popu-
lations at very high risk for CVD, such as minority popu-
lations and those residing in the ‘stroke belt’ of the
southeastern USA, where CVD rates are substantially
higher compared with national levels.9 Thus, we devel-
oped and evaluated a lifestyle and weight loss interven-
tion for residents of eastern North Carolina, with a
major focus on implementing a culturally adapted
Mediterranean-style dietary pattern while also promoting
physical activity. In this paper, we report the interven-
tion’s effect on diet and physical activity behaviors, CVD
risk factors, and weight loss through 24 months of
follow-up by participants’ diabetes status.
RESEARCH DESIGN AND METHODS
Study overview
The Heart Healthy Lenoir (HHL) Project was a collab-
orative research effort designed to reduce CVD risk and
disparities in CVD risk among Lenoir County, North
Carolina residents, as previously described.10 11 It was
funded by the National Heart, Lung, and Blood
Institute (NHLBI) as part of an initiative with the
National Cancer Institute ‘to develop and test multilevel
interventions to reduce health disparities.’12 This paper
focuses on participants who took part in the HHL life-
style study,11 one of three coordinated HHL studies
which also included a study to improve high blood pres-
sure (BP) management at local practices and a study
examining associations between genetic markers and
change in CVD risk factors. These studies were con-
ducted in Lenoir County because of its location in the
‘stroke belt’9 of eastern North Carolina, where rates of
CVD are higher than state and national averages13 and
because it has a large minority population (40%
African-American) that experiences disproportionally
higher rates of CVD.14 The HHL lifestyle study was
designed and conducted with input from a local com-
munity advisory committee10 and was approved and
monitored by the University of North Carolina’s
Institutional Review Board. Data were collected between
20 September, 2011 and 7 November, 2014.
The lifestyle study consisted of three phases as shown
in figure 1, which depicts the three sequential phases of
the study and the number of participants with and
without diabetes who took part in each component of
the intervention. Phase I, which lasted 6 months and was
the same for all study participants, focused on improving
diet quality and increasing physical activity. In Phase II,
which also lasted 6 months, participants with a body
mass index (BMI) ≥25 kg/m2 were offered an intensive
weight loss intervention while those with a BMI<25 kg/
m2 and those who declined the weight loss intervention
received a maintenance of lifestyle intervention. In
Phase III, participants who lost ≥8 lbs (3. 6 kg) at the
conclusion of Phase II were invited to take part in a year-
long, randomized controlled trial (RCT), comparing a
more intensive and less intensive maintenance of weight
loss intervention; a year-long maintenance of lifestyle
intervention was given to those who did not take part in
the RCT. As prior RCTs conducted by our research
team15–18 have shown that similar formats of lifestyle
and weight loss interventions are effective in improving
lifestyle and achieving weight loss among low socio-
economic status participants, we did not include a
control group for Phases I and II of this study.
Furthermore, our community advisory committee
strongly encouraged a study design in which all partici-
pants received ‘active treatment.’
Participants
The enrollment goal for this study, based on having an
adequate sample for the Phase III maintenance of
weight loss RCT, was 350 with about 150 participants
recruited from the community and 200 from the high
BP study, as previously described.11 19 Criteria for screen-
ing from the community were age ≥18 years and interest
in improving lifestyle behaviors to reduce CVD risk.
Screening criteria for the high BP study were age ≥18,
being an established patient at a participating practice,
and systolic BP≥150 mmHg when assessed during
routine care within the prior 12 months.
After obtaining verbal informed consent, research staff
conducted phone interviews to screen potential partici-
pants.11 If eligibility criteria were met, participants were
invited to an enrollment visit at a central research office
or at participating clinics. Written informed consent was
obtained prior to collecting baseline measures.
Participants attending the enrollment visit for the high
BP study were invited to also take part in the lifestyle
study until 200 agreed to do so.
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Intervention
Phase I (months 1–6)—lifestyle intervention
This intervention focused on dietary and physical activity
behaviors and did not address other aspects of lifestyle
relevant to CVD risk reduction, such as smoking cessation.
Further, the same intervention was given to those with and
without diagnosed diabetes. (All participants with diabetes
had type 2 diabetes). The lifestyle intervention was origin-
ally developed by Ammerman et al20 21 and subsequently
revised to emphasize carbohydrate quality as an important
Figure 1 Study flow diagram.
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component of a heart-healthy diet.15 Consistent with the
evolving literature suggesting frequent consumption of
food with high-quality fats (polyunsaturated and monoun-
saturated fats primarily from plant sources and fish) is also
important in reducing CVD risk in those with and without
diabetes,7 22–26 this study’s dietary intervention was further
modified to include a major focus on improving dietary
fat quality. These changes rendered the HHL lifestyle
intervention dietary pattern very similar to the
PREDIMED study’s nut intervention arm diet;7 therefore,
the dietary pattern was termed ‘Med-South’ because of its
intended use in the southeastern USA.
The intervention format and content have been previ-
ously published and described in detail.11 Phase I included
four monthly sessions delivered by a trained counselor
administered as hour-long individual counseling sessions
or 90 min group sessions given at a centrally located
research office or participating clinic. Participants chose
their preferred counseling format. About 75% of counsel-
ing time was devoted to dietary behaviors with the rest
focusing on physical activity. Dietary counseling included
culturally relevant content to improve fat quality (such as
increasing consumption of nuts, full-fat salad dressings
and mayonnaise, and vegetable oils), increase fruit and
vegetable consumption, promote fish and poultry intake
while reducing red and processed meat intake, and minim-
ize consumption of sugar-sweetened beverages,
high-sugar-content desserts, and snacks. Physical activity
counseling focused mostly on walking with a recom-
mended goal of at least 7500 steps/day or ≥30 min/day of
physical activity on ≥5 days/week. Spouses and friends
were invited to attend the counseling intervention sessions.
When participants could not physically attend counseling
sessions, telephone counseling was offered. Participants
also received a pedometer and activity logs to self-monitor
physical activity as well as a listing of local community
resources that promoted healthy eating (eg, farmers’
markets) and physical activity (eg, community parks).
Those participants who were co-enrolled in the high BP
study received a home BP monitor and were instructed to
measure their BP at least three times per week. They also
received monthly phone calls for a year, primarily promot-
ing BP medication adherence.
During counseling sessions, participants worked with
their counselor to create individually tailored action
plans to improve dietary and physical activity behaviors.
Dietary and physical activity tips were tailored to prob-
lematic lifestyle behaviors assessed on the baseline life-
style questionnaire. Dietary tips included recipe
suggestions from a southern-style cookbook that was
given to all participants. At the beginning of sessions 2–
4, the counselor and participants reviewed progress
made towards previously stated goals.
Phase II (months 7 through 12)—weight loss and
maintenance of lifestyle interventions
Participants with a BMI≥25 kg/m2 could choose to take
part in the weight loss intervention. Those who were not
eligible for the weight loss intervention (BMI<25 kg/m2)
and those who declined the intervention received a
maintenance of lifestyle intervention consisting of three
phone calls, as previously described.11 The weight loss
intervention was offered in two formats over ∼16 weeks:
16 weekly group sessions as previously tested,16 18 27 or
five group sessions plus 10 phone contacts (combination
intervention), as recently described.11 The major modifi-
cation from the previously tested weight loss interven-
tion was the focus on the Med-South dietary pattern and
addition of newer evidence-based behavioral compo-
nents (eg, daily self-weighing).28
Phase III (13–24 months)—weight loss and lifestyle
maintenance interventions
Participants who took part in the Phase II weight loss
intervention and lost ≥8 lbs (3.6 kg) were invited to take
part in the maintenance of weight loss RCT. All other
study participants received brief, quarterly maintenance
of lifestyle intervention phone calls (similar to Phase II),
as previously described.11 For the maintenance of weight
loss RCT, participants were randomized 1:1 to receive
either 36 phone contacts (24 weekly calls over 6 months
followed by 12 biweekly calls over 6 months; more inten-
sive intervention) or 18 phone contacts (12 biweekly
calls over 6 months followed by 6 monthly calls over
6 months; less intensive intervention).
Measures
Outcome measures were assessed at baseline, 6, 12, and
24 months. Previously validated questionnaires were
administered to assess lifestyle change including the
Dietary Risk Assessment (DRA) which assessed overall
diet quality,20 29 the brief Block fruit and vegetable ques-
tionnaire,30 a dietary fat quality screener,31 and a ques-
tionnaire to assess walking and overall physical
activity.32 33 In addition, the SF-12 (SF-12 instrument,
Quality Metric, Lincoln, RI) was administered to assess
quality of life. Weight was assessed by electronic scale
(Seca 874, Seca, Hanover, MD) as the average of two
measures to the closest tenth pound. Height was mea-
sured with a portable stadiometer at baseline only. BP
was calculated as the average of three measurements
recorded at 60 s intervals (Omron HEM-907XL, Omron
Healthcare, Lake Forest, IL) after being seated for
5 min. Blood lipids and glycated hemoglobin (A1c) were
assessed by a commercial laboratory (LabCorp,
Burlington, North Carolina, USA). At follow-up meas-
urement visits, questionnaires were administered to
assess acceptability of the intervention and adverse out-
comes. Participants received compensation for measure-
ment visits: $40 for enrollment, $25 for 6 and 12-month
visits, and $30 for the 24-month visit.
Sample size and statistical analysis
The enrollment goal of 350 participants was based on
having a sufficient sample (N=100) for the embedded
RCT of weight loss maintenance.11 In addition, the
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overall sample of 350 was considered sufficient to
describe the primary objective of the lifestyle interven-
tion to improve diet quality at 6-month follow-up, and
the major secondary objectives of improved diet quality,
physical activity, and weight loss at 12 and 24-month
follow-up.
Sample characteristics were summarized using descrip-
tive statistics, with subgroups by diabetes status and race.
Outcomes were assessed using pre–post changes by dia-
betes status and race with paired t-tests for continuous
outcomes, McNemar’s tests for binary outcomes, and χ2
tests for subgroup analysis when appropriate. Data are
reported for returnees at follow-up without imputation
for missing data. As described,11 among all study partici-
pants, weight loss was substantially less than anticipated
and observed in our prior weight loss studies.16 18 Only
27 participants overall (eight with diabetes) took part in
the maintenance of weight loss RCT. Given this small
number, weight loss results are reported in the aggregate
and not separately for those who took part in the RCT.
Because age, race, sex, education, and baseline weight
are potential confounders for weight loss, a linear
regression analysis was conducted adjusting for these
variables. Participants who became pregnant, had baria-
tric surgery, or were diagnosed with cancer (excluding
non-melanoma skin cancer or localized breast or pros-
tate cancer diagnosed by screening tests) were excluded
from analysis (eight overall, four with diabetes). SAS
V.9.3 was used for analysis.
RESULTS
Baseline characteristics
As outlined in detail elsewhere,11 of 642 individuals
assessed as eligible for this study, 366 (57%) attended
the enrollment visit and 339 (53%) completed all base-
line measurements and comprised the study sample,
including 134 recruited from the community and 205
from the clinic-based high BP study. Participants’ base-
line characteristics, by diabetes status then further cate-
gorized by race, are outlined in table 1.
A total of 124 (37%) participants had diabetes. The
overall average age was 56 years; participants with dia-
betes were older on average than those without diabetes
(59 vs 54 years). Men, particularly African-American
men, were underrepresented in the sample. More than
half of participants did not have any college education.
Those without diabetes and whites were more likely to
be married or living with a partner compared with
others. Most participants had health insurance (74%)
and this did not vary by diabetes status or race. Those
with diabetes were more likely to be unemployed due to
health reasons (31% vs 14%) and less likely to be cur-
rently employed full-time or part-time (34% vs 58%).
Median annual household income was <$40 000 overall
and <$20 000 among participants with diabetes.
In terms of CVD risk factors, reported rates of hyper-
tension were very high in the study (86% overall), which
may be largely attributed to how participants were
selected. Participants with diabetes were more likely to
report a history of hypertension (98% compared with
79%) and African-Americans reported higher rates of
hypertension than whites within each subgroup.
Participants with diabetes also reported higher rates of
prior coronary heart disease and CVD.
At baseline, overall diet quality and fat quality were
similar across diabetes status and race, while participants
with diabetes had slightly higher fruit and vegetable con-
sumption (average 3.7 compared with 3.3 servings/day).
Participants without diabetes reported much higher
total walking and total activity time at baseline (mean
105 and 171 min per week, respectively, compared with
67 and 112 min per week, respectively, among those with
diabetes). Participants with diabetes weighed more on
average than those without diabetes (103 kg compared
with 95 kg). Systolic BP was similar across all categories,
with a somewhat higher average for African-Americans
than whites (138 mmHg compared with 131 mmHg)
among participants with diabetes. Among those with dia-
betes, African-American participants had higher hemo-
globin A1c percentage at baseline than whites (8.0%
compared with 7.6%).
Outcomes
Figure 1 depicts the three sequential phases of the study
and the number of participants with and without dia-
betes that took part in each component of the interven-
tion and returned for follow-up. Follow-up rates at 6, 12,
and 24 months were ∼75% and were similar between
participants with and without diabetes. Lifestyle out-
comes are shown in table 2.
Overall diet quality, as assessed by the DRA total score,
improved by about 4 points at 6-month follow-up for all
participants and each of the subgroups. Improvement in
DRA total score was maintained at 12 and 24 months
compared with baseline among all subgroups except
white participants with diabetes. Fat quality score
improved by 1.4 points on average at 6 months with no
significant difference between subgroups by race or dia-
betes status, but this improvement was attenuated over
time for participants with diabetes. Only participants
without diabetes reported a statistically significant
increase in fruit and vegetable servings per day at 6, 12,
and 24-month follow-up. The improvement in the
summary score for drinks, desserts, and snacks was
higher among African-American participants with and
without diabetes compared with whites. Increased
walking time was sustained at 24 months among partici-
pants with diabetes and among African-Americans with
diabetes.
Physiological outcomes are shown in table 3.
Among all participants, there was a statistically signifi-
cant reduction in systolic BP of about 6 to 7 mmHg
across all follow-up time points. The reduction was
similar for those with diabetes and larger for
African-Americans with diabetes compared with whites.
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Table 1 Baseline characteristics: overall, by diabetes status then by race
Characteristics
Diabetes No Diabetes
Overall All African-American White All African-American White
n=339 n=124 n=89 n=34 n=215 n=130 n=83
Demographics
Age, mean (SE) 56 (0.6) 59 (0.9) 59 (1.1) 61 (1.7) 54 (0.8) 51 (1.1) 57 (1.2)
Female 260 (77) 93 (75) 70 (79) 22 (65) 167 (78) 111 (85) 54 (65)
Race
African-American 219 (65) 89 (72) 130 (61)
White 117 (35) 34 (28) 83 (39)
Education, years
≤8 (middle school or less) 16 (5) 7 (6) 4 (5) 3 (9) 9 (4) 7 (5) 2 (2)
9–11 (some high school) 45 (13) 25 (20) 22 (25) 2 (6) 20 (9) 13 (10) 7 (8)
12 (high school graduate) 128 (38) 46 (37) 36 (40) 10 (29) 82 (38) 58 (45) 24 (29)
13–15 (some college) 79 (23) 24 (19) 16 (18) 8 (24) 55 (26) 29 (22) 25 (30)
16 (college graduate) 49 (14) 14 (11) 9 (10) 5 (15) 35 (16) 17 (13) 17 (21)
>16 (graduate school) 22 (7) 8 (7) 2 (2) 6 (18) 14 (7) 6 (5) 8 (10)
Education: high school or less 189 (56) 78 (63) 62 (70) 15 (44) 111 (52) 78 (60) 33 (40)
Marital status
Married or living with a partner 159 (47) 51 (41) 32 (36) 19 (56) 108 (50) 50 (39) 57 (69)
Other 180 (53) 73 (59) 57 (64) 15 (44) 107 (50) 80 (62) 26 (31)
Currently have health insurance 251 (74) 94 (76) 68 (76) 25 (74) 157 (73) 88 (68) 67 (81)
Current employment
Working full time 124 (37) 25 (20) 18 (20) 7 (21) 99 (46) 64 (49) 33 (40)
Working part time 42 (12) 17 (14) 14 (16) 2 (6) 25 (12) 17 (13) 8 (10)
Do not work due to health reasons 69 (20) 38 (31) 26 (29) 12 (35) 31 (14) 17 (13) 14 (17)
Retired 53 (16) 26 (21) 18 (20) 8 (24) 27 (13) 8 (6) 19 (23)
Other 51 (15) 18 (14) 13 (15) 5 (15) 33 (15) 24 (19) 9 (11)
Annual household income
<$10 000 62 (20) 31 (29) 24 (32) 6 (18) 31 (16) 26 (22) 5 (7)
$10 000 to<$20 000 64 (21) 28 (26) 23 (31) 5 (15) 36 (18) 22 (19) 14 (18)
$20 000 to<$40 000 84 (28) 29 (27) 20 (27) 9 (27) 55 (28) 40 (34) 14 (18)
$40 000 to<$60 000 33 (11) 9 (8) 3 (4) 6 (18) 24 (12) 12 (10) 12 (16)
$60 000 to <$80 000 27 (9) 9 (8) 4 (5) 5 (15) 18 (9) 9 (8) 9 (12)
≥$80 000 34 (11) 2 (2) 0 (0) 2 (6) 32 (15) 10 (8) 22 (29)
CVD and risk factors for CVD
Known coronary heart disease 49 (14) 28 (23) 20 (23) 8 (24) 21 (10) 10 (8) 11 (13)
Known cardiovascular disease 62 (18) 33 (27) 23 (26) 10 (29) 29 (13) 14 (11) 15 (18)
Hypertension 291 (86) 121 (98) 88 (99) 32 (94) 170 (79) 107 (82) 63 (76)
Cholesterol
High (≥240 mg/dL) 187 (56) 82 (67) 57 (65) 24 (71) 105 (49) 53 (42) 52 (63)
Borderline (200–239 mg/dL) 46 (14) 8 (7) 7 (8) 1 (3) 38 (18) 26 (21) 11 (13)
Desirable (<200 mg/dL) 102 (30) 33 (27) 24 (27) 9 (27) 69 (33) 48 (38) 20 (24)
Diabetes 124 (37)
Current cigarette smoker 54 (16) 21 (17) 17 (19) 4 (12) 33 (15) 20 (15) 13 (16)
Packs of cigarettes smoked per day,
mean (SE) for current smokers
















































Outcomes for diastolic BP were similar. Of note, there
was very little change in participants’ use of blood
measure medication at follow-up (data not shown). For
those with diabetes, the number reporting use of BP
medication was unchanged at 6-month, one less at
12-month, and two less at 24-month follow-up. For those
without diabetes, use increased by one at 6, two at 12,
and two at 24-month follow-up. There was a trend
toward significant improvement in hemoglobin A1c at
12 months among participants with diabetes (−0.30%
(95% CI −0.63 to 0.02)/−3.3 mmol/mol (95% CI −6.9
to 0.2), p=0.07). Overall, there was a small decrease in
total and HDL cholesterol.
Weight loss was a major outcome of interest.
Participants with diabetes had significant, sustained, and
progressive weight loss compared with baseline at 6, 12,
and 24 months (mean −1.2 kg, −1.5 kg, and −3.7 kg,
respectively) across all intervention groups. White parti-
cipants with diabetes had greater weight loss than
African-American participants with diabetes. Weight
change for participants with diabetes at 12-month
follow-up (data not shown) by intervention group
selected at the start of the HHL weight program (start
of Phase II) was: −3.9 kg (95% CI −7.4 to −0.4, p=0.03)
for the group weight loss program (n=17); −2.6 kg (95%
CI −5.0 to −0.2, p=0.03) for the combination weight loss
program (n=27); and –0.2 kg (95% CI −2.0 to 1.6,
p=0.81) for the maintenance of lifestyle intervention
program (n=52). At 24-month follow-up (data not
shown), it was −5.2 kg (95% CI −9.6 to −0.8, p=0.2) for
the group weight loss program (n=18); −2.2 kg (95% CI
−4.6 to 0.1, p=0.06) for the combination weight loss
program (n=25); and –3.8 kg (95% CI −5.9 to −1.8,
p<0.001) for the maintenance of lifestyle intervention
program (n=50). After adjusting for age, race, sex, edu-
cation, and baseline weight, only participants with dia-
betes had significant sustained weight loss at 24 months
(p<0.0001) and participants with diabetes had signifi-
cantly more weight loss on average than participants
without diabetes (p=0.01).
Figure 2 depicts weight change (loss and gain) at
follow-up by diabetes status with cut points for weight
change from baseline of ≥2.5, ≥5, and ≥7.5%. Consistent
with mean weight loss, a greater proportion of participants
with diabetes demonstrated substantially greater weight
loss than gain at these time points, especially at 24 months.
At 24 months, 18 participants (20%) lost more than 7.5%
body weight while none gained this amount. For those
without diabetes, the percentages of those who lost and
gained weight at 24 months were similar.
From baseline to 24-month follow-up, 32 participants
(34%) with diabetes lost at least 5% body weight com-
pared with 25 participants (16%) without diabetes.
Percentages for ≥5% weight loss were similar between
African-Americans and whites with diabetes; however,
more African-American participants without diabetes
achieved ≥5% weight loss at 24 months than whites
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Percentages of participants with diabetes who achieved
≥5% weight loss at 24 months, by Phase II intervention
group, were (data not shown): 44% (95% CI 21 to 68) for
the group weight loss program (n=18); 24% (95% CI 7
to 41) for the combination weight loss program (n=25);
and 36% (95% CI 22 to 50) for the maintenance of life-
style intervention program.
At the conclusion of Phase I, 85 of 88 (97%) partici-
pants with diabetes and 151 of 154 (98%) without dia-
betes either strongly agreed or agreed that they would
recommend the lifestyle program to others. After Phase
II, among participants completing the acceptability
survey with diabetes, all in the group weight loss
program (n=12) and 16 of 19 (84%) in the combination













Mean, 95% CI Mean, 95% CI Mean, 95% CI
Dietary
DRA total score 235 4.4 (3.7 to 5.0)*** 227 3.3 (2.5 to 4.0)*** 226 3.0 (2.3 to 3.6)***
Diabetes (all) 86 4.2 (3.1 to 5.3)*** 86 3.0 (1.8 to 4.2)*** 84 2.0 (1.0 to 3.1)***
African-American 60 4.4 (2.9 to 5.9)*** 63 3.8 (2.3 to 5.3)*** 62 2.5 (1.2 to 3.7)***
White 25 4.0 (2.6 to 5.4)*** 22 1.1 (−0.6 to 2.8) 21 0.7 (−1.3 to 2.7)
No diabetes (all) 149 4.4 (3.6 to 5.3)*** 141 3.4 (2.5 to 4.4)*** 142 3.5 (2.7 to 4.3)***
African-American 95 4.7 (3.7 to 5.7)*** 93 4.1 (3.0 to 5.3)*** 96 3.3 (2.3 to 4.4)***
White 52 3.9 (2.5 to 5.4)*** 47 2.0 (0.3 to 3.7)* 45 3.7 (2.5 to 5.0)***
Fat quality screener score 229 1.4 (1.0 to 1.8)*** 225 1.0 (0.6 to 1.3)*** 224 0.7 (0.3 to 1.1)***
Diabetes (all) 84 1.3 (0.7 to 2.0)*** 85 1.2 (0.6 to 1.8)*** 83 0.3 (−0.3 to 1.0)
African-American 58 1.2 (0.4 to 2.0)** 62 1.5 (0.8 to 2.2)*** 61 0.4 (−0.3 to 1.1)
White 25 1.6 (0.4 to 2.7)** 22 0.4 (−0.3 to 1.2) 21 0.1 (−1.2 to 1.5)
No Diabetes (all) 145 1.4 (1.0 to 1.9)*** 140 0.8 (0.4 to 1.3)*** 141 0.8 (0.4 to 1.3)***
African-American 92 1.5 (1.0 to 2.1)*** 92 1.1 (0.6 to 1.6)*** 95 0.8 (0.3 to 1.4)**
White 51 1.2 (0.5 to 2.0)** 47 0.4 (−0.4 to 1.2) 45 0.9 (−0.1 to 1.9)
Fruit and vegetable servings per day 249 0.3 (0.1 to 0.5)* 253 0.5 (0.3 to 0.8)*** 250 0.4 (0.2 to 0.6)***
Diabetes (all) 93 −0.1 (−0.5 to 0.4) 98 0.2 (−0.3 to 0.7) 96 0.1 (−0.4 to 0.5)
African-American 67 −0.1 (−0.7 to 0.5) 75 0.2 (−0.4 to 0.8) 74 0.1 (−0.4 to 0.6)
White 25 0.1 (−0.4 to 0.7) 22 0.0 (−0.6 to 0.6) 21 0.1 (−0.6 to 0.7)
No Diabetes (all) 156 0.5 (0.3 to 0.7)*** 155 0.8 (0.5 to 1.1)*** 154 0.6 (0.3 to 0.9)***
African-American 101 0.5 (0.2 to 0.8)** 103 0.8 (0.4 to 1.1)*** 103 0.6 (0.2 to 0.9)**
White 53 0.5 (0.0 to 0.9)* 51 0.8 (0.3 to 1.2)*** 50 0.6 (0.2 to 1.1)**
Summary score for drinks, desserts, snacks 236 1.1 (0.9 to 1.3)*** 229 1.3 (1.1 to 1.6)*** 228 1.1 (0.8 to 1.3)***
Diabetes (all) 87 1.1 (0.7 to 1.4)*** 87 1.2 (0.8 to 1.6)*** 85 0.9 (0.5 to 1.3)***
African-American 61 1.1 (0.7 to 1.6)*** 64 1.3 (0.8 to 1.7)*** 63 1.1 (0.7 to 1.6)***
White 25 1.0 (0.5 to 1.5)*** 22 1.1 (0.3 to 1.8)** 21 0.1 (−0.7 to 1.0)
No diabetes (all) 149 1.1 (0.8 to 1.5)*** 142 1.4 (1.1 to 1.8)*** 143 1.2 (0.8 to 1.5)***
African-American 95 1.3 (0.9 to 1.8)*** 93 1.7 (1.2 to 2.1)*** 96 1.3 (0.9 to 1.8)***
White 52 0.7 (0.2 to 1.2)** 48 0.9 (0.4 to 1.4)*** 46 0.8 (0.3 to 1.3)**
Physical activity
Walking time, min/wk 249 64 (19 to 109)** 253 71 (28 to 113)** 250 22 (−13 to 56)
Diabetes (all) 93 101 (17 to 184)* 98 126 (58 to 194)*** 96 62 (11 to 113)*
African-American 67 119 (18 to 221)* 75 136 (52 to 220)** 74 75 (13 to 137)*
White 25 71 (−81 to 223) 22 117 (14 to 219)* 21 38 (−36 to 112)
No diabetes (all) 156 42 (−9 to 94) 155 36 (−17 to 89) 154 −3 (−49 to 42)
African-American 101 29 (−45 to 103) 103 19 (−53 to 91) 103 −17 (−82 to 47)
White 53 63 (8 to 118)* 51 68 (−3 to 138) 50 22 (−22 to 66)
Total physical activity time, min/wk 249 97 (36 to 158)** 253 83 (30 to 136)** 250 48 (−7 to 103)
Diabetes (all) 93 120 (19 to 221)* 98 109 (29 to 188)** 96 62 (−8 to 131)
African-American 67 136 (17 to 255)* 75 127 (32 to 223)** 74 89 (3 to 175)*
White 25 106 (−94 to 305) 22 74 (−63 to 212) 21 −5 (−91 to 81)
No Diabetes (all) 156 83 (6 to 159)* 155 67 (−3 to 137) 154 40 (−39 to 118)
African-American 101 86 (−17 to 189) 103 37 (−42 to 116) 103 28 (−76 to 132)
White 53 79 (−33 to 192) 51 125 (−15 to 265) 50 58 (−55 to 171)
Significance level:
*p<0.05; **p<0.01; ***p<0.001.
DRA, dietary risk assessment; min, minute; wk, week.
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Baseline to 6 months Baseline to 12 months Baseline to 24 months
Mean, 95% CI Mean, 95% CI Mean, 95% CI
Systolic BP, mm Hg 249 −6.4 (−8.7 to −4.1)*** 251 −6.2 (−9.0 to −3.3)*** 250 −7.3 (−9.9 to −4.6)***
Diabetes (all) 93 −7.1 (−11.3 to −3.0)*** 97 −5.8 (−10.9 to −0.6)* 96 −7.4 (−11.9 to −3.0)**
African-American 67 −8.6 (−13.9 to −3.2)** 74 −6.4 (−12.7 to −0.1)* 74 −9.3 (−14.6 to −4.0)***
White 25 −3.8 (−9.6 to 2.0) 22 −4.1 (−13.2 to 5.0) 21 −0.4 (−8.7 to 8.0)
No diabetes (all) 156 −5.9 (−8.7 to −3.2)*** 154 −6.4 (−9.7 to −3.1)*** 154 −7.1 (−10.5 to −3.8)***
African-American 101 −5.6 (−8.9 to −2.2)** 102 −7.3 (−11.6 to −3.1)*** 103 −7.9 (−12.2 to −3.5)***
White 53 −6.5 (−11.3 to −1.7)** 51 −4.3 (−9.5 to 0.8) 50 −5.6 (−10.7 to −0.5)*
Diastolic BP, mm Hg 249 −3.7 (−4.9 to −2.5)*** 251 −5.0 (−6.4 to −3.6)*** 250 −6.7 (−8.3 to −5.2)***
Diabetes (all) 93 −4.4 (−6.4 to −2.3)*** 97 −5.6 (−8.2 to −3.0)*** 96 −7.2 (−10.1 to −4.3)***
African-American 67 −4.6 (−7.2 to −2.1)*** 74 −5.8 (−8.8 to −2.7)*** 74 −8.2 (−11.7 to −4.7)***
White 25 −4.1 (−7.6 to −0.7)* 22 −4.7 (−10.0 to 0.6) 21 −3.3 (−8.3 to 1.7)
No diabetes (all) 156 −3.4 (−4.8 to −1.9)*** 154 −4.6 (−6.2 to −3.0)*** 154 −6.4 (−8.2 to −4.7)***
African-American 101 −2.8 (−4.8 to −0.9)** 102 −4.8 (−7.0 to −2.7)*** 103 −6.5 (−8.9 to −4.0)***
White 53 −4.3 (−6.5 to −2.1)*** 51 −3.9 (−6.2 to −1.6)*** 50 −6.3 (−8.5 to −4.1)***
Weight, kg 248 −0.7 (−1.2 to −0.3)** 250 −1.7 (−2.5 to −1.0)*** 247 −1.6 (−2.5 to −0.8)***
Diabetes (all) 92 −1.2 (−2.1 to −0.4)** 96 −1.5 (−2.9 to −0.2)* 93 −3.7 (−5.2 to −2.1)***
African-American 66 −1.1 (−2.0 to −0.3)** 73 −1.0 (−2.5 to 0.4) 71 −3.1 (−4.6 to −1.5)***
White 25 −1.6 (−4.0 to 0.7) 22 −3.3 (−6.9 to 0.4) 21 −5.5 (−9.9 to −1.2)*
No diabetes (all) 156 −0.4 (−0.9 to 0.1) 154 −1.8 (−2.7 to −1.0)*** 154 −0.4 (−1.4 to 0.6)
African-American 101 −0.7 (−1.4 to 0.0) 102 −2.2 (−3.4 to −1.1)*** 103 −0.9 (−2.2 to 0.4)
White 53 0.2 (−0.5 to 0.8) 51 −1.0 (−2.3 to 0.4) 50 0.9 (−0.8 to 2.5)
≥5% weight loss, % 248 9.3 (5.6 to 12.9) 250 23.2 (17.9 to 28.5) 247 23.1 (17.8 to 28.4)
Diabetes (all) 92 10.9 (4.5 to 17.3) 96 20.8 (12.7 to 29) 93 34.4 (24.7 to 44.1)
African-American 66 12.1 (4.1 to 20.2) 73 19.2 (10.0 to 28.4) 71 32.4 (21.3 to 43.5)
White 25 8.0 (0.0 to 18.8) 22 27.3 (8.3 to 46.2) 21 38.1 (16.9 to 59.3)
No diabetes (all) 156 8.3 (4.0 to 12.7) 154 24.7 (17.8 to 31.5) 154 16.2 (10.4 to 22.1)
African-American 101 11.9 (5.5 to 18.3) 102 26.5 (17.8 to 35.1) 103 18.5 (10.9 to 26.0)
White 53 1.9 (0.0 to 5.6) 51 19.6 (8.6 to 30.6) 50 10.0 (1.6 to 18.4)
HbA1c, %† 217 0.01 (−0.09 to 0.12) 220 −0.07 (−0.20 to 0.06)
Diabetes (all) 80 −0.11 (−0.38 to 0.17) 84 −0.30 (−0.63 to 0.02)
African-American 60 −0.10 (−0.45 to 0.25) 66 −0.33 (−0.72 to 0.06)
White 19 −0.20 (−0.60 to 0.20) 17 −0.28 (−0.85 to 0.28)
No diabetes (all) 137 0.08 (0.04 to 0.11)*** 136 0.07 (0.01 to 0.13)*
African-American 87 0.10 (0.05 to 0.14)*** 88 0.08 (0.01 to 0.16)*
White 48 0.05 (0.00 to 0.10) 47 0.05 (−0.03 to 0.13)
HbA1c, mmol/mol† 217 0.1 (−1.0 to 1.3) 220 −0.8 (−2.2 to 0.7)
Diabetes (all) 80 −1.2 (−4.2 to 1.9) 84 −3.3 (−6.9 to 0.2)
African-American 60 −1.1 (−4.9 to 2.7) 66 −3.6 (−7.9 to 0.7)
White 19 −2.2 (−6.6 to 2.2) 17 −3.1 (−9.3 to 3.1)
No diabetes (all) 137 0.9 (0.4 to 1.2)*** 136 0.8 (0.1 to 1.4)*
African-American 87 1.1 (0.5 to 1.5)*** 88 0.9 (0.1 to 1.7)*
White 48 0.5 (0.0 to 1.1) 47 0.5 (−0.3 to 1.4)
Total cholesterol, mg/dL‡ 221 −3.2 (−7.0 to 0.7) 211 −3.1 (−7.8 to 1.7)
Diabetes (all) 84 0.4 (−6.7 to 7.6) 83 −4.2 (−13.1 to 4.6)
African-American 66 −0.4 (−8.3 to 7.6) 65 −7.1 (−17.5 to 3.4)
White 17 6.9 (−9.5 to 23.3) 17 9.1 (−6.6 to 24.8)
No diabetes (all) 137 −5.4 (−9.8 to −1.1)* 128 −2.3 (−7.7 to 3.0)
African-American 89 −6.8 (−11.8 to −1.8)** 83 −2.4 (−8.9 to 4.2)
White 47 −2.5 (−11.0 to 6.0) 44 −2.2 (−11.6 to 7.2)
HDL cholesterol, mg/dL‡ 220 −1.6 (−2.8 to −0.4)* 211 −1.0 (−2.3 to 0.3)
Diabetes (all) 84 −2.0 (−4.0 to 0.0)* 83 −2.1 (−4.4 to 0.3)
African-American 66 −1.4 (−3.7 to 0.8) 65 −2.2 (−4.8 to 0.5)
White 17 −3.9 (−8.7 to 0.8) 17 −1.8 (−7.6 to 4.0)
No diabetes (all) 136 −1.3 (−2.8 to 0.2) 128 −0.3 (−1.7 to 1.2)
African-American 88 −1.6 (−3.6 to 0.4) 83 −0.1 (−2.1 to 2.0)
White 47 −0.9 (−3.1 to 1.2) 44 −0.6 (−2.6 to 1.3)
Significance level:
*p<0.05; **p<0.01; ***p<0.001.
†HbA1c was not measured at 24 months.
‡Lipids were not measured at 6 months.
BP, blood pressure; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein.
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weight loss program were satisfied or very satisfied with
the intervention. Participants without diabetes were simi-
larly satisfied. In addition, no adverse outcomes were
attributed to the intervention.
CONCLUSIONS
This study evaluated a lifestyle and weight loss interven-
tion promoting a Mediterranean-style diet in a way that
was designed to be appealing to residents of the south-
eastern USA residing in the ‘stroke belt,’ where the
population’s CVD risk is very high. Though this type of
dietary intervention has been carefully evaluated in
Europe,7 it has not been adapted for and assessed in
low-income and minority US populations. In this study,
the intervention was well received by participants and,
compared with baseline, there was improvement in self-
reported lifestyle behaviors, BP, and weight, with substan-
tially greater sustained weight loss observed for partici-
pants with diabetes.
Among participants with diabetes, our intervention
did not achieve the same degree of weight loss docu-
mented in the Diabetes Prevention Program (DPP)
study,34 which was > 5 kg at 24 months (20% of partici-
pants were African-American, average age 51). However,
in the small subgroup of participants (n=25) who
Figure 2 N and percentage of
participants, by diabetes status,
for weight change from baseline
to follow-up at 6, 12, and
24 months. Weight change is
shown for three cut points (≥2.5,
≥5, and ≥7.5% of baseline
weight). N, number.
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selected the group-based weight loss option, weight loss
at 24 months was >5 kg, as it was for all of the white par-
ticipants with diabetes. In essence, among participants
selecting the group-based weight loss format, weight loss
at 24 months in our low-income and high-minority
population was similar to that observed in the DPP.
Moreover, weight loss among all participants with dia-
betes was greater than in most weight loss studies enrol-
ling disadvantaged population groups.4
Different from the PREDIMED study, which reported
weight loss <0.5 kg at 24 months follow-up in all study
arms (all participants, not stratified by diabetes status),35
participants in our study with diabetes who selected the
lifestyle only option (which focused on diet quality and
physical activity, but not weight loss) lost 3.8 kg at
24-month follow-up. A possible explanation for weight
loss in this group of our study, as compared with
PREDIMED, is difference in baseline diet, with more
poor quality carbohydrates and processed food in the
American diet compared with the European diet36 and
particularly so in the southeastern USA.37–40 In this
setting of excess intake of poor quality carbohydrates, a
change to a Mediterranean-style, unrestricted fat diet,
may have positive metabolic and appetite-suppressing
effects, as recently outlined by Ludwig.41 Although the
dietary pattern advocated in this study was similar to the
PREDIMED intervention arms (especially the nut inter-
vention arm),7 we recommended regular consumption
of vegetable oils (high in polyunsaturated and monoun-
saturated fats) as opposed to four tablespoons of extra
virgin olive oil per day as tested in the PREDIMED olive
oil intervention arm. In this regard, it is worth noting a
recent publication assessing outcomes in two large
cohort studies which indicated diets higher in polyunsat-
urated and monounsaturated fats are associated with a
reduction in CVD mortality and total mortality.26
As illustrated in figure 2, among all participants with
diabetes, including the majority who did not elect to
take part in the weight loss intervention offered in Phase
II of the intervention, weight loss increased steadily over
the 24-month study period. This weight loss began
during Phase I, which focused on diet quality and phys-
ical activity, but not specifically on weight loss, and con-
tinued at about the same rate during Phases II and III.
The observed pattern of weight loss in this study was dif-
ferent from that observed in most other weight loss
studies, which is usually greatest weight loss in the short
term (6–12 months) with attenuation of weight loss
beyond 1 year.42 In a recent meta-analysis of weight loss
among named weight loss diet programs, only one of 10
programs achieved greater weight loss at 12 months than
at 6 months.6 Even in programs with intensive interven-
tions that include maintenance of weight loss compo-
nents such as the DPP43 and Look AHEAD,8 there was
attenuation in weight loss at 18 and 24 months, respect-
ively. A possible explanation for the observed sustained
weight loss in our study was that all participants received
some level of intervention over 24 months and unlike
most weight loss studies, which try to achieve weight loss
over 6 months, our approach was to focus on weight loss
over a longer time frame. Additionally, the
Mediterranean dietary pattern may have contributed to
the sustained weight loss over 24 months, as this dietary
pattern has previously been shown to be associated with
maintenance of weight loss.44
This study has several limitations including a pre–post
design without a control group. While the observed
changes may be due to the intervention, they could also
be due to other factors, including secular trends.
However, sustained weight loss among adults is uncom-
mon. For example, in the control groups of weight loss
RCTs such as DPP and Look AHEAD, average weight
loss at 24-month follow-up was <1kg.8 34 With regard to
secular trends in North Carolina during the time frame
of this study (2011 to 2014), there were no changes in
the rates of overweight and obesity as assessed by the
Centers for Disease Control and Prevention’s behavioral
risk factor surveillance system.45
Another major limitation is the sample size of this
study, especially with regard to outcomes by intervention
groups (group weight loss, combination weight loss, or
maintenance of lifestyle intervention) and race. Further,
because weight loss was less than expected at the end of
Phase II, as discussed in detail elsewhere,11 the sample
size for the ‘embedded’ RCT of weight loss maintenance
was so small that we did not undertake a formal analysis
of outcomes for this RCT. Another limitation is that life-
style outcomes were self-reported and may have been
exaggerated due to social desirability reporting bias.
Finally, our findings may not be generalizable to popula-
tions different from the sample enrolled from one com-
munity in eastern North Carolina.
The cost-effectiveness of an intervention is a very
important consideration for community-based and
clinic-based weight loss programs. Without a control
group, we did not undertake a cost-effectiveness analysis,
which is another limitation of this study. However, we
have previously reported a cost-effectiveness analysis for
the group-based intervention format that we tested in
Phase II, comparing it with a delayed intervention
control group.46 In that study, in which the weight loss
intervention was considered cost-effective (assuming
weight loss could be sustained over time), weight loss at
6-month follow-up was 3.7 kg in the intervention group,
very similar to the weight loss of 3.9 kg observed at the
completion of Phase II for our participants with diabetes
for our participants with diabetes who received the
group-based intervention.
The study has several strengths. First, is the relatively
unselected sample (few exclusion criteria were applied
and no run-in period) which enhances its generalizabil-
ity; second, it used a design that mimicked real-world
situations, allowing participants to choose between two
weight loss intervention formats or to focus on lifestyle
change without weight loss as a goal; third, the follow-up
was 74% at 24 months, which is a larger follow-up
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percentage and longer follow-up interval than reported
in many weight loss studies; and fourth, physiological
outcomes were obtained using standardized objective
measures.
In this study, with a relatively unselected sample,
largely minority and of lower socioeconomic status, the
tested Mediterranean-style dietary pattern, a pattern
associated with substantial reduction in CVD risk7 was
very well received. Among participants with diabetes,
there was sustained improvement in self-reported life-
style behaviors, BP, and weight change at 24-month
follow-up. Though the study did not have a control
group, our findings confirm the acceptability of a
Mediterranean-style dietary pattern among this very
high-risk population and suggest that this dietary pattern
may be associated with sustained weight loss. Further
study of interventions promoting this dietary pattern is
warranted in high-risk US populations with diabetes,
including RCTs that assess intermediate outcomes and
CVD events.
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